← back to search

Emily S. Ruiz

Harvard University · US
Area of research
Epidemiology · Oncology
Research interest
Research interests include Nonmelanoma Skin Cancer Studies, Cutaneous Melanoma Detection and Management, Cancer and Skin Lesions, and Cutaneous lymphoproliferative disorders research.
h-index
25
citations
2,989
works
197
NIH funding
primary concept
Medicine
email

Recent publications

riSCC: A personalized risk model for the development of poor outcomes in cutaneous squamous cell carcinoma
Journal of the American Academy of Dermatology 2025cited by 17position: lastdoi
Impact of immunosuppression on cutaneous squamous cell carcinoma outcomes
Journal of the American Academy of Dermatology 2025cited by 2position: middledoi
Efficacy and safety of cosibelimab in advanced cutaneous squamous cell carcinoma: Results from a Pivotal Open-label Study with a median follow-up of ≥2 years
Journal of the American Academy of Dermatology 2025cited by 1position: firstdoi
CLO25-055: Metastasis-Free Survival Prediction With the 40-Gene Expression Profile Test in Patients With Cutaneous Squamous Cell Carcinoma Risk Stratified According to the National Comprehensive Cancer Network Guidelines
Journal of the National Comprehensive Cancer Network 2025cited by 0position: firstdoi
Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: The Skin Care in Organ Transplant Patients in Europe-International Transplant Skin Cancer Collaborative metastases study, a prospective multicenter study
Journal of the American Academy of Dermatology 2024cited by 12position: middledoi
Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors
Annals of Oncology 2023cited by 37position: middledoi
Perioperative imaging for high-stage cutaneous squamous cell carcinoma helps guide management in nearly a third of cases: A single-institution retrospective cohort
Journal of the American Academy of Dermatology 2023cited by 10position: lastdoi
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
New England Journal of Medicine 2022cited by 299position: middledoi
Field cancerization: Definition, epidemiology, risk factors, and outcomes
Journal of the American Academy of Dermatology 2020cited by 173position: middledoi
Field cancerization: Treatment
Journal of the American Academy of Dermatology 2020cited by 66position: lastdoi
Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women’s Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma
JAMA Dermatology 2019cited by 195position: firstdoi
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer
Proceedings of the National Academy of Sciences 2019cited by 191position: middledoi
Incidence and mortality for cutaneous squamous cell carcinoma: comparison across three continents
Journal of the European Academy of Dermatology and Venereology 2019cited by 124position: middledoi
Clinical and Incidental Perineural Invasion of Cutaneous Squamous Cell Carcinoma
JAMA Dermatology 2017cited by 138position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Chrysalyne D. Schmults · Harvard University6 papers (2017–2023)Pritesh S. Karia · Columbia University3 papers (2017–2019)Anokhi Jambusaria‐Pahlajani · The University of Texas at Austin3 papers (2020–2025)Tyler J. Willenbrink · The University of Texas at Austin3 papers (2020–2025)Christine Cornejo · Johns Hopkins Medicine2 papers (2020–2020) · 2 papers (2025–2025)Kelsey E. Hirotsu · Palo Alto University2 papers (2025–2025)David Wang · Case Western Reserve University2 papers (2025–2025)Emily Granger · UNSW Sydney2 papers (2023–2025)Shlomo A. Koyfman · University of Iowa2 papers (2025–2025)Allison T. Vidimos · The Ohio State University Wexner Medical Center2 papers (2025–2025)Sarah T. Arron · College of San Mateo2 papers (2020–2020)Axel Hauschild · Princess Alexandra Hospital1 papers (2023–2023)Vincent Jeanselme · Carnegie Mellon University1 papers (2025–2025)Anne Lynn S. Chang · Stanford University Medical Center1 papers (2023–2023)Jennifer J. Siegel · The University of Texas at Austin1 papers (2025–2025)Fadi Murad · Tulane University1 papers (2023–2023)Adèle C. Green · University of Manchester1 papers (2019–2019)Lisa Licitra · University of Milan1 papers (2023–2023)David G. Brodland · University of Pittsburgh Medical Center1 papers (2025–2025)